Related Experiment Video
Updated: Jan 8, 2026
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Integrating multi-omics, network pharmacology, and experimental validation to unveil the molecular mechanisms of
Yiqun Dong1, Zhaosen Fan2, Xiaoxiao Li3,4
1Qilu Medical University, Zibo, Shandong, China.
Introduction:
This study employs an integrated approach combining multi-omics analysis, network pharmacology, machine learning, and experimental validation to elucidate the molecular mechanisms of Fructus Xanthii (Chinese name: Cang-Er-Zi) in treating asthma.
Methods:
Asthma-related differentially expressed genes (DEGs) were identified from GEO datasets (GSE63142 and GSE14787). Weighted gene co-expression network analysis (WGCNA) was performed on GSE14787. Active ingredient targets of Fructus Xanthii were predicted using TCMSP and SwissTargetPrediction. Integration included machine learning (RF, SVM, XGB), PPI network analysis, GO/KEGG enrichment, immune infiltration (CIBERSORT), molecular docking, molecular dynamics simulations, and in vivo validation in an ovalbumin-induced murine asthma model.
Results:
Yielded 3,755 DEGs and the MEblack module correlated with asthma. Identified 1,317 potential targets, with 100 intersecting DEGs. Hub targets included HSP90AB1, CCNB1, CASP9, CDK6, NR3C1, ERBB2, and CCK. Strong binding affinities (e.g., carboxyatractyloside with HSP90AB1 at -10.09 kcal/mol) and stable complexes were confirmed. Immune profiling showed altered cell populations. In vivo, Fructus Xanthii extract reduced inflammation, cytokines (TNF-α, IL-6, IL-1β, IL-5), and hub gene expression.
Discussion:
Fructus Xanthii exerts anti-asthmatic effects by modulating HSP90AB1/IL6/TNF and PI3K-AKT pathways, regulating inflammation, cell cycle, apoptosis, and immune homeostasis, providing empirical support for multi-target traditional Chinese medicine strategies in asthma management.
More Related Videos
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:24Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: